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Glutamate-induced excitotoxicity is common in the pathogenesis of many neurological
diseases. A pulsed electromagnetic field (PEMF) exerts therapeutic effects on the nervous
system, but its specific mechanism associated with excitotoxicity is still unknown. We
investigated the role of PEMF exposure in regulating glutamate-induced excitotoxicity
through the endocannabinoid (eCB) system. PEMF exposure improved viability of HT22
cells after excitotoxicity and reduced lactate dehydrogenase release and cell death. An
eCB receptor 1 (CB1R) specific inhibitor suppressed the protective effects of PEMF
exposure, even though changes in CB1R expression were not observed. Elevation
of N-arachidonylethanolamide (AEA) and 2-arachidonylglycerol (2-AG) following PEMF
exposure indicated that the neuroprotective effects of PEMF were related to modulation
of the eCB metabolic system. Furthermore, CB1R/ERK signaling was shown to be
an important downstream pathway of PEMF in regulating excitotoxicity. These results
suggest that PEMF exposure leads to neuroprotective effects against excitotoxicity by
facilitating the eCB/CB1R/ERK signaling pathway. Therefore, PEMF may be a potential
physical therapeutic technique for preventing and treating neurological diseases.
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INTRODUCTION
Neurological diseases are tightly associated with synaptic dysfunction involving an imbalance of
excitatory and inhibitory transmitters. Overproduction of glutamate, which is the most important
excitatory transmitter, in the synaptic cleft induces excitotoxicity and is the primary mechanism of
acute brain injury, including stroke and brain trauma (Luo et al., 2011; Lai et al., 2014). However,
clinical trials have reported unsatisfactory results for drugs designed to treat excitotoxicity
(McConeghy et al., 2012). Neurosurgery can resolve mass effects caused by lesions, but it has no
effect at the cellular level. Hence, novel therapies are required for treating excitotoxicity following
brain injury.
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Due to the closed cranial cavity and the blood–brain barrier,
it is difficult to conduct traditional non-invasive treatments and
develop drugs. A pulsed electromagnetic field (PEMF), as a non-
invasive physical factor, can penetrate all tissues including skin,
muscles, and bones (Yamaguchi-Sekino et al., 2011). Over the
past decade, therapeutic effects of PEMF have been reported in
a series of basic and clinical studies (Hug and Röösli, 2012). In
the central nervous system (CNS), PEMF affects neurogenesis
and neural recovery under normal or pathological conditions
(Gramowski-Voß et al., 2015; Hei et al., 2016). Although the
protective role of PEMF in stroke and brain trauma has been
indicated, the biological mechanisms related to excitotoxicity
at the cellular and molecular levels that could explain the
therapeutic effects of PEMF have not been identified.
Endocannabinoids (eCBs), including N-
arachidonylethanolamide (AEA) and 2-arachidonylglycerol
(2-AG), are endogenous lipid mediators that act as key
modulators of synaptic function (Tantimonaco et al., 2014;
Parsons and Hurd, 2015). By activating cannabinoid receptors
(CB1R and CB2R) expressed in the CNS, eCBs can regulate
glutamatergic synaptic transmission and plasticity (Castillo
et al., 2012). Since activation of eCB signaling inhibits
excitotoxicity, it plays an important role in neuroprotection
against ischemic/traumatic brain injury (Shohami et al., 2011;
Benyó et al., 2016). In addition, previous studies showed that
responsiveness of neural cells and tissues to physical stimuli such
as electroacupuncture and transcranial magnetic stimulation was
related to modulation of eCB signaling (Li et al., 2012; Wang
H. N. et al., 2014). However, the biological effects of PEMF on
neural eCB signaling is still unclear.
Hence, our objectives were to determine the biological effects
of PEMF on excitotoxicity, clarify the relationship between PEMF
and eCB signaling, and investigate the possible mechanism
underlying PEMF regulation of excitotoxicity and eCB signaling.
Through these studies, we hope to elucidate further the
therapeutic effects of PEMF and its cellular mechanism in the




HT22 cells (a mouse hippocampal cell line) were obtained
from the Institute of Biochemistry and Cell Biology, SIBS, CAS
(Shanghai, China). The cells were grown in Dulbecco’s Modified
Eagle Medium (Thermo Scientific, Waltham, MA, USA) plus
10% fetal bovine serum (Hyclone Laboratories, Logan, UT) and
1% antibiotics (penicillin/streptomycin). One day before the
experiments, cells were seeded in 6-well, 24-well, or 96-well
culture dishes. Following treatment with glutamate and PEMF
exposure, the cells were subjected to various measurements as
described below.
Abbreviations: PEMF, pulsed electromagnetic field; eCB, endocannabinoid; CB1R,
eCB receptor 1; CNS, central nervous system; AEA, N-arachidonylethanolamide;
2-AG, 2-arachidonylglycerol; DAGL, diacylglycerol lipase; NAPE-PLD, N-acyl
phosphatidylethanolamine phospholipase D; MAGL, monoacylglycerol lipase;
FAAH, fatty acid amide hydrolase.
Antibodies and Reagents
Primary antibodies to CB1R, DAGL, NAPE-PLD, MAGL, and
FAAH were obtained from Cayman Chemical Inc. (Ann Arbor,
MI, USA). Antibodies to p-ERK1/2, ERK1/2, and β-actin
were obtained from Cell Signaling Technology (Beverly, MA,
USA). The secondary antibodies for immunoblots were HRP-
conjugated anti-rabbit, anti-mouse, and anti-goat IgG (Santa
Cruz Biotechnology, Dallas, TX, USA). L-glutamate, ACEA,
ACPA, AM251, AM281, 2-AG, AEA, PD98059, and U0126 were
obtained from Tocris Bioscience (Avonmouth, Bristol, UK).
PEMF Treatment
The PEMF stimulation system was established as previously
described (Wang J. et al., 2014). In brief, this system comprised a
PEMF generator (GHY-III, FMMU, Xi’an, China; China Patent
No. ZL02224739.4) and a solenoid surrounded with 400 turns
of enamel-coated copper wire. A cell culture plate was placed in
the center of the solenoid and received an open-circuit output
wave form the PEMF at a frequency of 15Hz. The peak-to-
peak magnetic field was 9.6 Gauss. Measurement accuracy of the
electromagnetic field output was confirmed using a gaussmeter
(Model 455 DSP gaussmeter, Lake Shore Cryotronics). In the
control group, each cell culture plate was placed in another
solenoid that was also connected to the pulse generator but
without an output waveform (no stimulation).
Western Blot Analysis
After various treatments, HT22 cells in 6-cm dishes were washed
three times with ice-cold PBS and lysed with lysis buffer
containing protease inhibitor mixture tablets and phosphatase
inhibitor mixture tablets (PhosSTOP, Roche Applied Science,
Mannheim, Germany). Protein concentration of the supernatant
was determined using a BCA protein kit (Beyotime, Shanghai,
China). Proteins were separated by 10–15% and 10% SDS-
PAGE gels and transferred to nitrocellulose membranes (Thermo
Scientific). The membranes were soaked in 5% nonfat milk
solution in Tris-buffered saline with 0.05% Tween 20 (TBST) for
1 h at room temperature and then incubated overnight at 4◦C
with the appropriate primary antibody (CB1, 1:800; DAGL, 1:800;
NAPE-PLD, 1:500; MAGL, 1:500; FAAH, 1:800; p-ERK, 1:800;
ERK, 1:1000; β-actin, 1:2500). Membranes were washed in TBST
and incubated for 1 h at room temperature with the secondary
antibodies diluted in blocking buffer. Immunoreactivity was
detected by SuperSignal West Pico Chemiluminescent Substrate
(Thermo Scientific). Optical densities of the bands were
quantified using an image analysis system with ImageJ (Scion
Corporation).
eCB Measurements
AEA and 2-AG were detected by LC-MS/MS (API 5000, AB
SCIEX) as previously described (Valdeolivas et al., 2013). Briefly,
cell lipid extracts were mixed with internal standards and
analyzed by HPLC. After separation of AEA and 2-AG, MS
analysis was conducted in the selected ion-monitoring mode.
The m/z-values of 356 and 348 were used for deuterated and
undeuterated AEA, while m/z-values of 384.35 and 379.35
were used for deuterated and undeuterated 2-AG. Calibration
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curves were produced using synthetic AEA and 2-AG. Analyst
Software (version 1.4; Applied Biosystems) was used to evaluate
concentrations of calibration standards, quality controls, and
samples.
Cell Viability Assay
Cell viability assays were performed using The Cell Proliferation
Reagent WST-1 (Roche) following the manufacturer’s protocol
and culture cells (at a concentration of 0.5–5 × 104) in
microplates (tissue culture grade, 96 wells, flat bottom) at a
volume of 100 µL/well. After treatment, 10 µL Cell Proliferation
Reagent WST-1 was added to each well and incubated for 4 h
at 37◦C and 5% CO2. For background control (absorbance of
culture medium plus WST-1 in the absence of cells), 100 µL
culture medium and 10 µL Cell Proliferation Reagent WST-
1 were added to a single well. Reaction mixtures were shaken
thoroughly for 1min on a shaker, and absorbance of the
samples was measured against the background control blank in
a microplate (ELISA) reader (Bio-Rad, Hercules, CA, USA).
Lactate Dehydrogenase (LDH) Assay
Cytotoxicity was determined bymeasuring release of LDH, which
is a cytoplasmic enzyme and a marker of membrane integrity.
LDH release into the culture medium was detected using
a diagnostic kit according to the manufacturer’s instructions
(Nanjing Jiancheng Bioengineering Institute, Nanjing, China).
Briefly, 50 µL of supernatant from each well was collected
to assay LDH release. The samples were incubated with the
reduced form of nicotinamide-adenine dinucleotide (NADH)
and pyruvate for 15min at 37◦C, and the reaction was stopped
by adding 0.4mol/L NaOH. Activity of LDH was calculated from
absorbance at 440 nm, and background absorbance from culture
medium that was not used for cell culture was subtracted from
all absorbance measurements. The results were normalized to
maximal LDH release, which was determined by treating control
wells for 60min with 1% Triton X-100 to lyse all cells.
Statistical Analysis
Statistical evaluation was done with GraphPad Prism software,
version 5.0 (La Jolla, CA, USA). Significant differences between
experiments were assessed by an ANOVA followed by Bonferroni
post-hoc test (more than two groups) or unpaired t-test (two
groups); P < 0.05 was considered significant. The data represent
the values obtained from six to eight independent experiments,
each of which was performed in duplicate.
RESULTS
PEMF Reduces Glutamate-Induced
Excitotoxicity in HT22 Cells
To investigate the biological effects of PEMF on glutamate-
induced excitotoxicity, HT22 cells were treated with PEMF using
three different protocols: (1) PEMF exposure for 4 h followed by
glutamate treatment for 24 h; (2) PEMF exposure and glutamate
treatment for 4 h followed by glutamate treatment for 20 h; (3)
PEMF exposure for 4 h followed by glutamate treatment for 24 h
with PEMF exposure for 4 h in the middle of glutamate treatment
(Figure 1A).
After glutamate treatment for the indicated times (0, 1,
3, 6, 12, 18, and 24 h) under three different PEMF exposure
protocols, viability of HT22 cells was higher than that of HT22
cells without PEMF treatment (Figure 1B), and PEMF exposure
decreased LDH release after glutamate treatment (Figure 1C).
Protocol 3 of PEMF exposure showed the most significant
neuroprotective effects against excitotoxicity after glutamate
treatment for 24 h (Figures 1D,E). Thus, this protocol was used
for further experiments and defined as the PEMF+ Glu group.
Involvement of CB1R in PEMF-Induced
Neuroprotective Effects against
Excitotoxicity
To clarify involvement of cannabinoid receptors in biological
effects of PEMF, HT22 cells were treated with PEMF and
glutamate. Expression of CB1R was not changed by PEMF in
glutamate-treated HT22 cells (Figures 2A,B). Then, HT22 cells
were pretreated with agonists of CB1R (ACEA and ACPA) and
antagonists of CB1R (AM251 and AM281) before PEMF and
glutamate treatments. Although activation of CB1R by ACEA
and ACPA reduced glutamate-induced cell injury, these agonists
did not affect the protective effects of PEMF against glutamate-
induced excitotoxicity (Figures 2C,D). In contrast, AM251 and
AM281, which inhibited CB1R, suppressed the PEMF-induced
increase in cell viability and decrease in LDH release after
glutamate treatment (Figures 2C,D).
Neuroprotective Effects of Pemf Depend
on Elevation of 2-AG and AEA
To determine the role of PEMF in influencing production of
eCBs, levels of two eCBs, 2-AG and AEA, were assessed in HT22
cells after treatment with PEMF for indicated times. Both 2-AG
and AEA levels in HT22 cells were significantly elevated at 2, 3,
and 4 h after PEMF treatment (Figures 2E,F). After glutamate
treatment, either the 2-AG or AEA level was increased in HT22
cells under normal conditions or HT22 cells treated with PEMF
(Figures 2G,H). However, levels of these eCBs in PEMF-treated
cells were significantly higher than those of cells under normal
conditions (Figures 2G,H).
PEMF affects the eCB-Related Enzymatic
System
To investigate involvement of the eCB-related enzymatic
system in PEMF-induced neuroprotective effects, expression
of diacylglycerol lipase (DAGL, an enzyme involved in
producing 2-AG), monoacylglycerol lipase (MAGL, an enzyme
involved in degrading 2-AG), N-acyl phosphatidylethanolamine
phospholipase D (NAPE-PLD, an enzyme involved in producing
AEA), and fatty acid amide hydrolase (FAAH, an enzyme
involved in degrading AEA) were tested in HT22 cells under
various conditions. After PEMF treatment, expression of DAGL
and NAPE-PLD was increased, while expression of MAGL and
FAAH was decreased in HT22 cells (Figures 3A–E). Although
this elevation of DAGL and NAPE-PLD expression induced
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FIGURE 1 | Neuroprotective effects of PEMF against glutamate-induced excitotoxicity. HT22 cells were treated with different PEMF and glutamate protocols
as shown in (A). Cell viability was measured by WST assay (B) and neurotoxicity was measured by LDH assay (C). The data represent mean ± standard error from
eight experiments. F-value (B) = 10.38, F-value (C) = 5.908, *P < 0.05 vs. the glutamate (Glu) group. After glutamate treatment for 24 h, cell viability (D) and LDH
release (E) were compared between the three protocols. The data represent mean ± standard error from eight experiments. F-value (D) = 48.82, F-value (E) =
18.83, *P < 0.05 vs. protocol 1 group, #P < 0.05 vs. protocol two group.
FIGURE 2 | PEMF exposure regulated eCB/CB1R signaling. HT22 cells were treated with PEMF and glutamate according to protocol 3 for 24 h. Expression of
CB1R was examined by western blot analysis (A). The data represent mean ± standard error from 6 experiments (B). After pretreatment with ACEA (30 µM), ACPA
(30 µM), AM251 (10 µM), and AM281 (10 µM), cell viability (C) and neurotoxicity (D) were measured by WST and LDH assays, respectively. The data represent mean
± standard error from eight experiments. F-value (C) = 42.51, F value (D) = 14.27, *P < 0.05 vs. vehicle group. After single PEMF exposure for indicated times,
synthesis of AEA (E) and 2-AG (F) was assayed by LC-MS/MS. The data represent mean ± standard error from six experiments. F-value (E) = 9.823, F-value (F) =
10.56, *P < 0.05 vs. control (Con) group. After treatment with PEMF and glutamate according to protocol 3 for 24 h, synthesis of AEA (G) and 2-AG (H) was assayed
by LC-MS/MS. The data represent mean ± standard from six experiments. F-value (G) = 5.806, F value (H) = 7.496, #P < 0.05 vs. control (Con) group. *P < 0.05
vs. Glu group.
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FIGURE 3 | Effects of PEMF exposure on expression of the eCB enzymatic system. After single PEMF exposure for 4 h, expression of DAGL, NAPE-PLD,
MAGL, and FAAH were examined by western blot analysis (A). The data represent mean standard ± error from six experiments (B–E). *P < 0.05 vs. Con group. After
treatment with PEMF and glutamate according to protocol 3 for 24 h, expression of DAGL, NAPE-PLD, MAGL, and FAAH were examined by western blot analysis (F).
The data represent mean ± standard error from six experiments (G–J). F-value (I) = 7.365, F-value (J) = 5.563, *P < 0.05 vs. Glu group.
by PEMF was not significant after glutamate treatment, PEMF
also reduced expression of MAGL and FAAH in HT22 cells
undergoing excitotoxicity (Figures 3F–J).
Activation of CB1R-ERK Signaling
Contributes to the Neuroprotective Effects
of PEMF
CB1R-ERK signaling has been implicated in regulating neuronal
injury after excitotoxicity. To determine the role of CB1R-
ERK signaling in neuroprotection induced by PEMF, HT22
cells were treated with PEMF. PEMF increased ERK1/2
phosphorylation in HT22 cells following glutamate treatment
(Figures 4A,B). Pretreatment with ERK1/2 inhibitors, PD98059
or U0126, reduced the neuroprotective effects of PEMF
against glutamate-induced excitotoxicity (Figures 4C,D). In the
presence of AM251, an antagonist of CB1R, PEMF-induced
phosphorylation of ERK1/2 was suppressed in glutamate-treated
cells (Figures 4E,F).
DISCUSSION
The combination of low frequency magnetic fields and induction
of microcurrents constitutes a basic mechanism underlying the
biological effects of PEMF (Yamaguchi-Sekino et al., 2011). The
benefits of PEMF have been evaluated by basic research and
clinical trials in many countries. Application of PEMF exhibited
therapeutic efficacy on bone fractures, skin ulcers, and lower back
pain (Hei et al., 2016). Recent studies have shown that PEMF
is a safe and non-invasive approach for management of several
neurological diseases, including Alzheimer’s disease (Arendash
et al., 2010), Parkinson’s disease (Vadalà et al., 2015), multiple
sclerosis (Lappin et al., 2003), and brain injury (Rasouli et al.,
2012; Pena-Philippides et al., 2014). However, the molecular
mechanisms responsible for the therapeutic effects of PEMF on
these diseases are still unclear.
Previous studies have shown that PEMF could modulate
inflammation after traumatic brain injury by inhibiting
production of pro-inflammatory factor IL-1β (Rasouli et al.,
2012). Similar results were obtained from PEMF exposure
after brain ischemia, which indicated that PEMF influences
neuroinflammation via elevation of anti-inflammatory IL-
10 and reduction of pro-apoptotic tumor necrosis factor
(Pena-Philippides et al., 2014). In addition to inflammation,
excitotoxicity induced by overproduction of excitatory
transmitters, such as glutamate, participates in various
pathophysiological processes of neurological diseases, especially
acute brain injury (stroke and brain trauma) (Chamorro
et al., 2016; Hinzman et al., 2016). In an attempt to reduce
glutamate-induced excitotoxicity by PEMF at the cellular level,
we showed that PEMF exposure could efficiently increase cell
viability and inhibit LDH release in HT22 cells. This supports
the hypothesis that glutamate-induced excitotoxicity is another
target for the neuroprotective effects of PEMF against acute
brain injury. In addition, we tried three different protocols
for applying PEMF. Although a single PEMF exposure before
(protocol 1) or after (protocol 2) glutamate treatment improved
cell viability, a double PEMF exposure (protocol 3) showed better
neuroprotective effects compared with a single PEMF exposure.
This result suggests that multiple PEMF exposures with specific
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FIGURE 4 | Regulation of CB1R-ERK signaling by PEMF exposure. HT22 cells were treated with PEMF and glutamate according to protocol 3 for 24 h.
Expression of p-ERK1/2 and ERK1/2 was examined by western blot analysis (A). The data represent mean ± standard error from six experiments (B). F-value (B) =
6.144, *P < 0.05 vs. Glu group. After pretreatment with PD98059 (40 µM) and U0126 (20 µM), cell viability (C) and neurotoxicity (D) were measured by WST and
LDH assays, respectively. The data represent mean ± standard error from eight experiments. F-value (C) = 58.65, F-value (D) = 15.01, *P < 0.05 vs. vehicle group.
After pretreatment with AM251 (10 µM), expression of p-ERK1/2 and ERK1/2 was examined by western blot analysis (E). The data represent mean ± standard error
from six experiments (F). F-value (F) = 8.537, *P < 0.05 vs. vehicle group.
intervals might be a potential method for reduction of neuronal
injury.
CB1R is highly expressed in glutamatergic synapses and can
be activated by AEA and 2-AG. Since these two eCBs are
produced by almost every neural cell, eCBs/CB1R signaling plays
a significant role in regulating brain function (Xu and Chen,
2015). Considerable data support induction of this signaling
system following exposure to physical treatments including
magnetic and electric stimuli, which protect neural cells or the
brain against various impact injuries (Wang et al., 2011; Mori
et al., 2014). In this study, we found that CB1R could be a novel
downstream molecule in the biological effects induced by PEMF.
A CB1R inhibitor reduced neuroprotective effects due to PEMF
exposure, even though PEMF exposure did not affect expression
of CB1R. This indicates that PEMF might modulate activity
of CB1R by regulating metabolism of eCBs, another important
factor in the eCB system.
AEA was the first eCB isolated from the nervous system; it
acts as an agonist in both the eCB and endovanilloid systems.
Another major eCB, 2-AG, is specific for CB1R and CB2R and
is present at higher concentration than AEA in the nervous
system (Di Marzo et al., 2015). eCBs have been regarded as
significant inhibitory mediators in synaptic excitation and have
been shown to play neuroprotective roles in brain injuries by
suppressing excitotoxicity (Xu and Chen, 2015). After confirming
the relationship between PEMF and the eCB system as well
as CB1R signaling, we found that levels of both AEA and 2-
AG were elevated by PEMF exposure of cells under normal
conditions. This effect induced by PEMF was also observed
during glutamate-induced excitotoxicity. These results support
the hypothesis based on previous experiments that PEMF
modulates eCBs/CB1R signaling by influencing levels of eCBs
and that the complex biosynthesis and degradation of eCBs is
regulated by PEMF exposure.
Several enzymatic processes are involved in the metabolism
of eCBs. AEA is synthesized from the hydrolysis of NAPE when
catalyzed by NAPE-PLD enzyme. Production of 2-AG depends
on the action of DAGL, which induces hydrolysis of DAGs. In
contrast, FAAH contributes to the hydrolysis of AEA, while the
hydrolysis of 2-AG is mediated by MAGL (Di Marzo et al., 2015).
In this study, results suggested that PEMF exposure induced the
elevation of NAPE-PLD and DAGL expression and reduction of
FAAH and MAGL, leading to accumulation of eCBs. Although
the effect of PEMF on changes in FAAH and DAGL during
excitotoxicity was not significant, FAAH and MAGL were also
regulated by PEMF exposure. Thus, we believe that the enzymatic
system responsible for metabolism of eCBs is an important
target of PEMF for neuroprotection. The different changes in
enzymatic systems between cells under normal conditions and
cells undergoing excitotoxicity might be related to the influence
Frontiers in Neuroscience | www.frontiersin.org 6 February 2017 | Volume 11 | Article 42
Li et al. PEMF Regulates Endocannabinoid System
of glutamate on these enzymes, which counteracts the effects of
PEMF exposure.
Activation of ERK signaling has been shown that induced
the survival of neurons after glutamate-induced excitotoxicity
(Ortuño-Sahagún et al., 2014). PEMF has been shown to
activate ERK signaling in bone metabolism, but its role in
regulation of ERK signaling in the CNS is not fully understood.
The present study provides evidence that PEMF exposure
promotes phosphorylation of ERK after excitotoxicity. Inhibition
of this process by a specific ERK inhibitor reversed the
neuroprotective effects of PEMF. In addition, activation of
intracellular ERK signaling by CB1R is a crucial mechanism
for neuroprotection (Kokona and Thermos, 2015). Further
results showed that inactivation of CB1R could suppress PEMF-
induced phosphorylation of ERK, indicating that PEMF exposure
enhanced CB1R-ERK signaling. Taken together, we found that
activation of ERK signaling was an essential downstream
mechanism for PEMF-mediated regulation of the eCB/CB1R
system and its neuroprotective effects against excitotoxicity.
There were several limitations in the present study. First,
variation of stimulus conditions, including magnetic field
intensity, frequency, duration, and time-varying mode, could
change the biological effects of PEMF. Second, our results
were obtained only from cellular experiments, which avoids
influences from individual variation and complexity of animals
or humans. Third, glutamate-induced excitotoxicity could not
represent neurological diseases even though it is a crucial
mechanism during pathogenesis of these diseases. Therefore,
further studies of neurological effects of PEMF should be
designed and conducted in animal models to elucidate its
potential therapeutic effects and mechanisms. After ensuring the
safety of PEMF, preclinical or clinical trials are needed to clarify
its significance in clinical application.
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